Skip to content
Clinical Trials – home
Centre Hospitalier Regional Universitaire
Sponsor

Centre Hospitalier Regional Universitaire

France 2 Place Saint Jacques, Cs 51804, 25030 Besançon, France

About the sponsor

The sponsor funds studies in hepatocellular carcinoma, biliary tract carcinoma, glioblastoma, colorectal cancer, and melanoma, with strong interest in immune checkpoint inhibition, therapeutic cancer vaccines, and combinations with anti-angiogenic therapy or chemotherapy.

  • Hepatocellular carcinoma
  • Glioblastoma
  • Colorectal cancer
  • Cutaneous melanoma
  • Biliary tract carcinoma

Research activity also includes metastatic disease, unresectable tumors, and neoadjuvant or maintenance immunotherapy strategies.

About Specializations

Centre Hospitalier Regional Universitaire runs clinical trials in conditions such as Colorectal cancer metastatic, Anal squamous cell carcinoma, Biliary neoplasm, Colorectal cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

14 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Mycophenolic Acid
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Carboplatin
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:CHUR Of Besançon
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Dapagliflozin Propanediol Monohydrate
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Centre Hospitalier Regional Universitaire

Malignant melanoma

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Centre Hospitalier Regional Universitaire
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Centre Hospitalier Regional Universitaire

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.